It is a GLP-1 receptor agonist, its just not as effective, it produces an 8% weight loss, its going off patent, I believe in 2023 or 24 and when it goes off patent, I think that there will be generics to at least make that drug available at a very reasonable cost
A temporary plateau does not automatically mean the dose should increase
Why am I so tired after starting semaglutide
The only good news here is that this is also the thing that we have the most control over
J Am Coll Nutr 27(2):299305 Barnett SD, Buxton ILO (2017) The role of S -nitrosoglutathione reductase (GSNOR) in human disease and therapy
Our Face & Body Whitening Treatment is designed to brighten your skin tone, reduce pigmentation, and enhance overall skin radiance